Renal Denervation Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

Renal Denervation Catheters Market Overview

The Renal Denervation Catheters market size was valued at $22.5 million in 2022. Renal denervation, also known as renal sympathetic denervation (RSD), is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in the nerve activity which ultimately reduces the blood pressure in patients with resistant hypertension.

Renal Denervation Catheters Market Outlook, 2022-2033 ($ Million)

For more insights into the Renal Denervation Catheters market forecast, download a free report sample

The Renal Denervation Catheters market research report is built to visualize quantitative market trends within Endoscopy Devices therapeutic area. The model discusses in detail the impact of COVID-19 on the Renal Denervation Catheters market for the year 2020 and beyond. Each of the covered 39 country’s color-coded and fully sourced market models are equipped with epidemiology-based indications with procedure volumes.

Renal Denervation Catheters Market Dynamics

The global prevalence of hypertension is one of the largest drivers in the renal denervation market. It is estimated that over 1 billion people worldwide have hypertension and about 9.4 million deaths are associated with complications related to it every year. In addition to unhealthy lifestyle habits and a growing aging population, metabolic risk factors such obesity play an important role in the increasing prevalence of hypertension.

Therefore, factors such as the high prevalence of hypertension and the usefulness of the treatment for resistant hypertensive patients will propel the market growth in the coming years.

Renal Denervation Catheters Market Segments

The Renal Denervation Catheters market primarily consists of Radiofrequency Catheters, Ultrasound Catheters, and Micro-infusion Catheters. Radiofrequency Catheters led the Renal Denervation Catheters market in 2022.

Renal Denervation Catheters Market Analysis by Segments, 2022 (%)

For more insights into the Renal Denervation Catheters market segments, download a free report sample

Renal Denervation Catheters Market Segmentation by Regions

The key regions in the Renal Denervation Catheters market are North America, Europe, Asia Pacific, and South Central America. The global Renal Denervation Catheters market is dominated by North America in 2022. However, the market of Renal Denervation devices in North America has slowed over the years due to the failure of the Symplicity HTN-3 clinical trial and the expiration of the device license in Canada. The most recent research, however, showed a persistent blood pressure drop in patients who underwent renal denervation, even after 3 years, and was presented at the 2021 American College of Cardiology meeting. It is expected that successful clinical trials in the US will result in the significant expansion of the market in the future.

Renal Denervation Catheters Market - Competitive Landscape

Some of the leading companies in the Renal Denervation Catheters market are Medtronic Plc, Boston Scientific Corp, Abbott laboratories, ReCor Medical Inc, and Others. Medtronic Plc held the largest share of the Renal Denervation Catheters market in 2022.

Renal Denervation Catheters Market Analysis by Companies, 2022 (%)

To know more about the leading companies in the Renal Denervation Catheters market, download a free report sample

Segments Covered in the Report

Renal Denervation Catheters Segments Outlook (Value, $ Million, 2015-2033)

• Radiofrequency Catheters
• Ultrasound Catheters
• Micro-infusion Catheters

Renal Denervation Catheters Regional Outlook (Value, $ Million, 2015-2033)

• North America
• Europe
• Asia Pacific
• South Central America

Key Inclusions

Currently marketed Renal Denervation Catheters and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Renal Denervation Catheters market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices, and market values by segment.

Global, Regional, and Country level market specific insights:

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Renal Denervation Catheters market.
• Competitive dynamics insights and trends provided for the Renal Denervation Catheters market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic Plc, Boston Scientific Corp, Abbott laboratories, Otsuka Holdings Co Ltd, and Others.

Countries covered: United States, Canada, Mexico, France, Germany, Italy, Spain, United Kingdom, Russia, Austria, Greece, Sweden, Switzerland, Australia, China, India, Japan, South Korea, Brazil, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –

• CMO executives who must have a deep understanding of the Renal Denervation Catheters marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base to make decisions about supplier selection and management.

Private equity investors need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to –

• Understand the impact of COVID-19 on the Renal Denervation Catheters market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the Renal Denervation Catheters market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Renal Denervation Catheters market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Renal Denervation Catheters from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.